Recurrent Angioedema (DBCOND0115806)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Lanadelumab	A monoclonal antibody targeted against kallikrein which is used to treat attacks of hereditary angioedema.	Plasma kallikreintarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03749135	Dupilumab in Chronic Spontaneous Urticaria	Dupilumab	treatment	2	completed